BECN1 and non-small cell lung carcinoma: In other reports, however, it could enhance the sensitivity of NSCLC cells to CDDP treatment [17] and enhance the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy [32].